Evaluation of factors affecting the frequency and clinical course of COVID-19 in patients using anti-TNF-alpha agents.

Published in: Revista da Associacao Medica Brasileira (1992) (2021)

We concluded that the patients treated with anti-TNF-alpha agents having COVID-19 might have mild clinical course and better prognosis.

Keyphrases